BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35280487)

  • 1. Prognostic value of an immunohistochemical signature in patients with pulmonary squamous cell carcinoma undergoing complete surgical resection.
    Lin C; Xi Y; Yu H; Chen X; Shen W
    J Thorac Dis; 2022 Feb; 14(2):536-545. PubMed ID: 35280487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of an immunohistochemical signature in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy.
    Meng J; Zhang J; Xiu Y; Jin Y; Xiang J; Nie Y; Fu S; Zhao K
    Mol Oncol; 2018 Feb; 12(2):196-207. PubMed ID: 29160958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prognostic nomogram integrating novel biomarkers identified by machine learning for cervical squamous cell carcinoma.
    Li Y; Lu S; Lan M; Peng X; Zhang Z; Lang J
    J Transl Med; 2020 Jun; 18(1):223. PubMed ID: 32503630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of an Immunohistochemical Signature in Patients With Head and Neck Mucosal Melanoma.
    Xu QQ; Li QJ; Huang CL; Cai MY; Zhang MF; Yin SH; Lu LX; Chen L
    Front Immunol; 2021; 12():708293. PubMed ID: 34394109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Differences in Clinicopathologic and Prognostic Characteristics Between Surgically Resected Peripheral and Central Lung Squamous Cell Carcinoma.
    Lin MW; Huang YL; Yang CY; Kuo SW; Wu CT; Chang YL
    Ann Surg Oncol; 2019 Jan; 26(1):217-229. PubMed ID: 30456676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of an Immunohistochemical Signature in Patients With Bladder Cancer Undergoing Radical Cystectomy.
    Wu J; Wen JM; Wang YC; Luo WJ; Wang QF; Lv H; Dai B; Ye DW; Su HC; Zhu YP
    Front Oncol; 2021; 11():641385. PubMed ID: 33842349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Nomogram based on cell growth-related Biomarkers for Oral Squamous Cell Carcinoma.
    Shuai Y; Duan Y; Zhou M; Yue K; Liu D; Fang Y; Wang Y; Wu Y; Zhang Z; Wang X
    J Cancer; 2021; 12(17):5153-5163. PubMed ID: 34335932
    [No Abstract]   [Full Text] [Related]  

  • 8. A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma.
    Ji GW; Zhu FP; Zhang YD; Liu XS; Wu FY; Wang K; Xia YX; Zhang YD; Jiang WJ; Li XC; Wang XH
    Eur Radiol; 2019 Jul; 29(7):3725-3735. PubMed ID: 30915561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical Signature Add Prognostic Value in Patients With Early and Intermediate Hepatocellular Carcinoma Underwent Curative Liver Resection.
    Bai Y; Lian Y; Chen X; Wu J; Lai J; Qiu F; Zhou S; Zhu Z; Tian Y; Wang Y; Yang Y; Yan M
    Front Oncol; 2020; 10():616263. PubMed ID: 33585243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
    Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
    Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
    [No Abstract]   [Full Text] [Related]  

  • 11. The prognostic index PRIMA-PI combined with Ki67 as a better predictor of progression of disease within 24 months in follicular lymphoma.
    Hu J; Gao F; Zhao J; Song W; Wang Y; Zheng Y; Wang L; Han W; Ma L; Wang J; Bai M; Guan T; Xi Y; Zhang H; Qiu L; Su L
    Front Oncol; 2023; 13():1090610. PubMed ID: 37427106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
    Yang K; Tian J; Zhang B; Li M; Xie W; Zou Y; Tan Q; Liu L; Zhu J; Shou A; Li G
    Oral Oncol; 2019 Nov; 98():85-91. PubMed ID: 31569054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine learning classifiers for predicting 3-year progression-free survival and overall survival in patients with gliomas after surgery.
    Zhang B; Yan J; Chen W; Dong Y; Zhang L; Mo X; Chen Q; Cheng J; Liu X; Wang W; Zhang Z; Zhang S
    J Cancer; 2021; 12(6):1604-1615. PubMed ID: 33613747
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreased sphingomyelin (t34:1) is a candidate predictor for lung squamous cell carcinoma recurrence after radical surgery: a case-control study.
    Takanashi Y; Funai K; Eto F; Mizuno K; Kawase A; Tao H; Kitamoto T; Takahashi Y; Sugimura H; Setou M; Kahyo T; Shiiya N
    BMC Cancer; 2021 Nov; 21(1):1232. PubMed ID: 34789180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic model predicting the long-term cancer-specific survival for patients with hypopharyngeal squamous cell carcinoma.
    Tang X; Pang T; Yan WF; Qian WL; Gong YL; Yang ZG
    BMC Cancer; 2020 Nov; 20(1):1095. PubMed ID: 33176731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram based on clinical characteristics and serological inflammation markers to predict overall survival of oral tongue squamous cell carcinoma patient after surgery.
    Lin YW; Kang WP; Huang BL; Qiu ZH; Wei LF; Zhang B; Ding TY; Luo Y; Liu CT; Chu LY; Guo HP; Xu YW; Peng YH
    BMC Oral Health; 2021 Dec; 21(1):667. PubMed ID: 34961504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Assessment of Novel Predictive Nomograms Based on APRI for Hepatitis B Virus-associated Small Solitary Hepatocellular Carcinoma with Stereotactic Body Radiotherapy.
    Lai L; Su T; Liang Z; Lu Y; Hou E; Lian Z; Gao H; Zhu X
    J Cancer; 2020; 11(22):6642-6652. PubMed ID: 33046985
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery.
    Qiu Q; Duan J; Deng H; Han Z; Gu J; Yue NJ; Yin Y
    Front Oncol; 2020; 10():1398. PubMed ID: 32850451
    [No Abstract]   [Full Text] [Related]  

  • 20. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
    Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
    Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.